# CliniCARE-Bench: Clinical Calibrated Audit of Medical Reasoning in EHR

## Basic info

* Title: CliniCARE-Bench: Clinical Calibrated Audit of Medical Reasoning in EHR
* Authors: Veronica Chatrath, Bryan Zhu, George Pu, Jingxuan Fan, Apaar Shanker, Varun Ursekar, Anahita Sharma, Jason Qin, Keqi Han, Soham Dinesh Tiwari, Soham Dan, Vijay Kalmath, Yuan (Christy) Li, Daniel Yue Zhang, Chenguang Wang, Zainab Doctor, Zhijun Yin, Nigam H. Shah, Yuan Xue
* Year: 2026
* Venue / source: arXiv
* Link: https://arxiv.org/abs/2608.07796
* Date surfaced: 2026-08-17
* Why selected in one sentence: It shows that clinical-agent accuracy can look acceptable while the underlying investigation is still shortcut-ridden, over-committed, and poorly grounded.

## Quick verdict

* Highly relevant

I inspected the arXiv HTML full text. This is a strong domain-specific benchmark paper because it evaluates clinical investigation as an evidence-grounded agent workflow rather than another polite medical QA game.

## One-paragraph overview

CliniCARE-Bench evaluates retrospective clinical audit over longitudinal EHR data in a governed tool environment. It covers **25** clinician-validated scenarios instantiated as **750** patient-specific MIMIC-IV cases, each requiring systems to retrieve and reconcile structured and free-text evidence, apply governing policy, and return one of four verdicts: Yes, No, Indeterminate due to lack of data, or Indeterminate due to medical ambiguity. The benchmark scores more than verdict accuracy: it measures patient-evidence grounding, policy grounding, process adherence, calibrated abstention, reliability, and efficiency. The most useful result is that standard leaderboard accuracy flatters systems. Across **16** agentic systems, four-way accuracy ranges from **65.3%** to **76.1%**, but defect-free accuracy is **4.8** to **14.8** points lower and can reorder the ranking.

## Model definition

### Inputs
Systems receive patient-specific clinical audit scenarios plus access to governed tools over structured records, free-text notes, and policy materials.

### Outputs
They output a verdict, an investigation trace, and a report whose grounding and process quality can be replayed and scored.

### Training objective (loss)
There is no trained benchmark model. This is an evaluation framework with adjudicated reference verdicts and process scoring.

### Architecture / parameterization
The benchmark combines clinician-validated scenarios, replayable patient-level cases, a logged tool environment, four-way verdict labels, defect-aware scoring, and metrics for evidence grounding, policy use, process adherence, abstention, and efficiency.

## Key questions this summary must address

### 1. What problem is the paper trying to solve?
It is trying to solve the mismatch between tidy medical-benchmark accuracy and the real demands of defensible clinical record investigation.

### 2. What is the method?
The method is to benchmark agentic clinical audit as a replayable investigation task over longitudinal EHR data, with scoring that punishes shortcutting and rewards grounded abstention.

### 3. What is the method motivation?
Clinical deployment depends on whether a system can investigate a messy record, justify what it found, follow policy, and know when the record cannot settle the case, not just on whether it blurts out the correct final label.

### 4. What data does it use?
It uses **750** real-patient-derived MIMIC-IV cases spanning **25** clinician-validated scenarios.

### 5. How is it evaluated?
It evaluates **16** agentic systems under a governed tool environment and scores verdict accuracy, defect-free accuracy, evidence grounding, process adherence, calibration, over-commitment, over-abstention, and efficiency.

### 6. What are the main results?
Across the full cohort, four-way accuracy spans **65.3%** to **76.1%**, but defect-free accuracy is **4.8** to **14.8** points lower and can reorder the leaderboard. On the 148-case development subset, Opus 5 reaches **71.6%** accuracy, GPT-5.5 **70.9%**, and Gemini-3.1-Pro **70.3%**, but the top tier is statistically unresolved. More importantly, every single system over-commits more than it over-abstains: over-commitment ranges from **26.4%** to **60.4%**, while over-abstention ranges from **5.3%** to **16.8%**.

### 7. What is actually novel?
The novelty is the benchmark contract itself: it separates lack of data from medical ambiguity, scores defect-free correctness, and treats investigation quality as a first-class object rather than a hidden intermediate.

### 8. What are the strengths?
The benchmark is domain-realistic, replayable, clinically grounded, and far less naive than standard medical QA. The defect-free metric and abstention split both produce useful signal that plain accuracy would hide.

### 9. What are the weaknesses, limitations, or red flags?
It is still a benchmark paper, not a new clinical reasoning system. The cases are retrospective and MIMIC-IV-derived, the scenario set is finite, and some leaderboard differences remain statistically unresolved on the development subset.

### 10. What challenges or open problems remain?
The open problems are how well this benchmark generalizes across institutions, whether its process criteria cover the right real deployment failure modes, and how to connect benchmark improvements to actual clinical workflow benefit.

### 11. What future work naturally follows?
Future work should expand the scenario set, test additional institutions and record systems, and use the benchmark to study interventions that reduce over-commitment without collapsing into useless abstention.

### 12. Why does this matter for cabbageland?
Because it is a sharp example of mechanism-aware evaluation. The paper shows that a decent-looking final answer rate can coexist with bad investigation habits, and that better metrics can surface the difference cleanly.

### 13. What ideas are steal-worthy?
Separate missing evidence from genuine ambiguity. Use defect-free correctness, not answer-only correctness. Log and replay the full investigation trace. Score over-commitment and over-abstention separately instead of pretending they are the same axis.

### 14. Final decision
Keep as a preserved note. It is domain-specific, but the evaluation design principles are broadly reusable.

## 6. Mandatory critical angles

The paper is strongest on evaluation realism, calibrated abstention, and exposing hidden failure modes behind raw accuracy. It is weaker where all benchmark papers are weak: the value now depends on whether the field actually uses it and whether the scenarios keep pace with deployment reality.

## 7. Writing style

The right tone is approving and slightly grim. The leaderboard looks fine until the paper shows why it should not reassure anyone.

## 8. Repository output format

Saved as a preserved paper note because the defect-free and evidence-grounded evaluation design is likely to transfer beyond clinical audit.
